Balk SP, Ko YJ, Bubley GJ (2003) Biology of prostate-specific antigen. J Clin Oncol 21(2):383–391
Article CAS PubMed Google Scholar
Emery J (2023) Prostate-specific antigen testing: Evolving evidence and shared decision making. Aust J Gen Pract 52(3):87
Welch HG, Albertsen PC (2009) Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986–2005. J Natl Cancer Inst 101(19):1325–1329
Article PubMed PubMed Central Google Scholar
Greene KL, Albertsen PC, Babaian RJ, Carter HB, Gann PH, Han M et al (2009) Prostate specific antigen best practice statement: 2009 update. J Urol 182(5):2232–2241
Article CAS PubMed Google Scholar
Ilic D, Djulbegovic M, Jung JH, Hwang EC, Zhou Q, Cleves A et al (2018) Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis. BMJ 362:k3519
Article PubMed PubMed Central Google Scholar
Tarhan F, Orçun A, Küçükercan I, Camursoy N, Kuyumcuoglu U (2007) Effect of hemodialysis on serum complexed prostate-specific antigen levels. Scand J Urol Nephrol 41(5):382–386
Article CAS PubMed Google Scholar
Williams PB, Eastham JA, Culkin DJ, Mata JA, Venable DD, Sartor O (1997) Influence of hepatic function on serum levels of prostate specific antigen. J Urol 158(5):1867–1869
Article CAS PubMed Google Scholar
Ku J, Kim ME, Lee NK, Park YH, Ahn JO (2003) Influence of age, anthropometry, and hepatic and renal function on serum prostate-specific antigen levels in healthy middle-age men. Urology 61(1):132–136
Wang A, Lazo M, Carter HB, Groopman JD, Nelson WG, Platz EA (2019) Association between liver fibrosis and serum PSA among U.S. Men: National Health and Nutrition Examination Survey (NHANES), 2001–2010. Cancer Epidemiol Biomarkers Prev 28(8):1331–1338
Zorbozan NAİ, Serten E, Fırat E (2023) The Change in tPSA, fPSA and f/tPSA levels in men undergoing hemodialysis effect of hemodialysis on serum PSA levels. Acıbadem Üniversitesi Sağlık Bilimleri Dergisi 14(2):326–331
Tzanakis I, Kazoulis S, Girousis N, Kagia S, Spandidakis V, Karefillakis N et al (2002) Prostate-specific antigen in hemodialysis patients and the influence of dialysis in its levels. Nephron 90(2):230–233
Article CAS PubMed Google Scholar
Sasagawa I, Kubota Y, Hayami S, Adachi M, Nakada T, Miura H, Imai K (1998) Serum levels of total and free prostate specific antigen in men on hemodialysis. J Urol 160(1):83–85
Article CAS PubMed Google Scholar
Djavan B, Shariat S, Ghawidel K, Güven-Marberger K, Remzi M, Kovarik J et al (1999) Impact of chronic dialysis on serum PSA, free PSA, and free/total PSA ratio: is prostate cancer detection compromised in patients receiving long-term dialysis? Urology 53(6):1169–1174
Article CAS PubMed Google Scholar
Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC et al (1994) Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 151(5):1283–1290
Kitai Y, Matsubara T, Funakoshi T, Horimatsu T, Muto M, Yanagita M (2016) Cancer screening and treatment in patients with end-stage renal disease: remaining issues in the field of onco-nephrology. Renal Replacement Therapy 2(1):33
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (2008) Cancer statistics, 2008. CA Cancer J Clin 58(2):71–96
Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB et al (1999) Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 354(9173):93–99
Article CAS PubMed Google Scholar
Kleinclauss F, Thuret R, Murez T, Timsit MO (2016) Urologic malignancies in renal transplant candidates and recipients. Prog Urol 26(15):1094–1113
Article CAS PubMed Google Scholar
Monath JR, Burkart JM, Freedman BI, Pittaway DE, Russell GB, Assimos DG (1993) Effects of hemodialysis on prostate-specific antigen. Urology 42(4):398–400
Article CAS PubMed Google Scholar
Horinaga M, Kitamura K, Saito S, Ukimura O, Nakanoma T, Okihara K et al (2007) Prostate cancer screening with prostate-specific antigen in hemodialysis patients. Urol Int 78(4):334–337
Article CAS PubMed Google Scholar
Sumura M, Yokogi H, Beppu M, Honda H (2003) Diagnostic value of serum prostate-specific antigen in hemodialysis patients. Int J Urol 10(5):247–250
Gomez M, Arias-Guillén M, Maduell F (2023) An extended kinetic model-based correction factor equation to account hemodialysis post-treatment hemoconcentration. Int J Artif Organs 46(5):314–317
Article CAS PubMed Google Scholar
Montero D, Haider T, Nägele MP, Barthelmes J, Cantatore S, Sudano I et al (2020) Effects of hemodialysis on blood volume, macro- and microvascular function. Microvasc Res 129:103958
Article CAS PubMed Google Scholar
Mustafa MA-AB (2006) Effect of hemodialysis on total, free and percent-free prostate-specific antigen. Affrican J Urol 12:75–78
García-Sánchez C, Corchuelo-Maillo C, Congregado-Ruiz CB, Ocón-Revuelta EM, Osman-García I, Conde-Sánchez JM, Medina-López RA (2013) PSA levels in patients on hemodialysis treatment. Arch Esp Urol 66(10):939–944
Morton JJ, Howe SF, Lowell JA, Stratta RJ, Taylor RJ (1995) Influence of end-stage renal disease and renal transplantation on serum prostate-specific antigen. Br J Urol 75(4):498–501
Article CAS PubMed Google Scholar
Kearney G, Chen MH, Mula-Hussain L, Skelton M, Eren MF, Orio PF et al (2023) Burden of prostate cancer in the Middle East: A comparative analysis based on global cancer observatory data. Cancer Med 12(23):21419–21425
Article PubMed PubMed Central Google Scholar
Abbasi-Kangevari M, Saeedi Moghaddam S, Ghamari SH, Azangou-Khyavy M, Malekpour MR, Rezaei N et al (2022) The burden of prostate cancer in North Africa and Middle East, 1990–2019: Findings from the global burden of disease study. Front Oncol 12:961086
Article PubMed PubMed Central Google Scholar
Al-Abdin OZ, Al-Beeshi IZ (2018) Prostate cancer in the Arab population. An Overview Saudi Med J 39(5):453–458
Daher M, Telvizian T, Dagher C, Abdul-Sater Z, Massih SA, Chediak AE et al (2021) High rates of advanced prostate cancer in the Middle East: Analysis from a tertiary care center. Urol Ann 13(4):418–423
Comments (0)